Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats

Published:2017-11-15 Issue:2 Volume:41 Page:266-273
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:J vet Pharmacol Therap

Author:

Hoenig M.¹^ORCID,Clark M.²,Schaeffer D. J.²,Reiche D.³

Affiliation:

1. Department of Clinical Veterinary Medicine; College of Veterinary Medicine; University of Illinois; Urbana IL USA

2. Comparative Biosciences; College of Veterinary Medicine; University of Illinois; Urbana IL USA

3. Boehringer Ingelheim Vetmedica GmbH; Ingelheim Germany

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvp.12467/fullpdf

Reference39 articles.

1. Renal sodium-glucose transport: Role in diabetes mellitus and potential clinical implications;Bakris;Kidney International,2009

2. Effect of kidney disease on glucose handling (including genetic defects);Calado;Kidney International. Supplement,2011

3. Paradoxical insight into whole metabolic adaptations following SGLT2 inhibition;Cefalu;The Journal of Clinical Investigation,2014

4. SGLT2 inhibition-A novel strategy for diabetes treatment;Chao;Nature Reviews. Drug Discovery,2010

5. Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats;Clark;Journal of Veterinary Internal Medicine,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13

2. Sodium‐glucose transport protein 2 inhibitor use in the management of insulin dysregulation in ponies and horses;Journal of Veterinary Pharmacology and Therapeutics;2024-07-10

3. Efficacy and safety of once daily oral administration of sodium‐glucose cotransporter‐2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats;Journal of Veterinary Internal Medicine;2024-06-17

4. Short‐term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo‐controlled, double‐blind, study;Journal of Veterinary Internal Medicine;2023-10-21

5. The Future of Diabetes Therapies;Veterinary Clinics of North America: Small Animal Practice;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3